result of these and other factors. We
assume no obligation to update forward- looking statements to reflect
actual performance or results, changes in assumptions or changes in other
factors affecting forward-looking information, except to the extent
required by applicable securities laws.
Accuray Incorporated
Unaudited Condensed Consolidated Statements of
Operations
(in thousands, except per share data)
Three months ended Years ended
June 28, June 30, June 28, June 30,
2008 2007 2008 2007
Net revenue:
Products $35,553 $34,729 $152,374 $110,320
Shared ownership programs 2,191 2,842 10,262 10,090
Services 11,842 5,651 38,808 16,860
Other 1,353 772 8,937 3,182
Total net revenue 50,939 43,994 210,381 140,452
Cost of revenue:
Costs of products 14,851 13,100 67,183 43,363
Costs of shared ownership
programs 290 672 2,517 2,637
Costs of services 7,851 4,781 26,865 12,269
Costs of other 1,051 525 6,864 2,144
Total cost of revenue 24,043 19,078 103,429 60,413
Gross profit 26,896 24,916 106,952 80,039
Operating expenses:
Selling and marketing 10,611 10,765 42,726 37,889
Research and development 8,405 7,510 32,880 26,775
General and administrative 8,460 7,060 32,280 23,915
Total oper
'/>"/>
SOURCE Accuray Incorporated Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 Related biology technology :1.
Accuray Incorporateds CEO to Speak at Piper Jaffray 19th Annual Health Care Conference2.
Accuray Announces New Treatment Planning Service Offering3.
Accuray to Present at Citi Investment Research Small & Mid-Cap Conference4.
Accuray Wins Innovations in Healthcare(SM) ABBY Award5.
Accuray Incorporateds CEO to Speak at CitiGroup Healthcare Conference6.
Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients7.
YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 268.
Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering9.
BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.10.
Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets11.
China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results